Uji Yukitaka, Kuze Manami, Matubara Hisashi, Doi Motoaki, Sasoh Mikio
Department of Ophthalmology, Mie University School of Medicine, Edobashi 2-174, Tsu 514-8507, Japan.
Doc Ophthalmol. 2003 Jan;106(1):37-41. doi: 10.1023/a:1022404630736.
The effects of the beta1-selective adrenergic antagonist betaxolol on electroretinography (ERG) were studied in the isolated and arterially perfused cat eye. Betaxolol increased the perfusion flow rate, significantly at the administrations of more than 50 microM concentrations and induced a dose-related, reversible increase in the amplitudes of both the a-wave and b-wave of ERG. These results suggest that the calcium-channel blocking mechanism of betaxolol has a beneficial influence on ocular blood flow and retinal electrical activity in response to light. As it is known that ERG is a good indicator of the functional integrity of the retina, this indicates that betaxolol could be an ideal drug for treating glaucoma in which ischemia is involved to some extent.
在离体并经动脉灌注的猫眼上研究了β1选择性肾上腺素能拮抗剂倍他洛尔对视网膜电图(ERG)的影响。倍他洛尔增加了灌注流速,在浓度超过50微摩尔时显著增加,并引起ERG的a波和b波振幅呈剂量相关的可逆性增加。这些结果表明,倍他洛尔的钙通道阻滞机制对眼血流量和视网膜对光的电活动有有益影响。由于已知ERG是视网膜功能完整性的良好指标,这表明倍他洛尔可能是治疗某种程度上涉及缺血的青光眼的理想药物。